GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Belite Bio Inc (NAS:BLTE) » Definitions » Other Current Receivables

BLTE (Belite Bio) Other Current Receivables : $0.59 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Belite Bio Other Current Receivables?

Belite Bio's Other Current Receivables for the quarter that ended in Dec. 2024 was $0.59 Mil.

Belite Bio's quarterly Other Current Receivables stayed the same from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($0.00 Mil) but then increased from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($0.59 Mil).

Belite Bio's annual Other Current Receivables increased from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.87 Mil) but then declined from Dec. 2023 ($0.87 Mil) to Dec. 2024 ($0.59 Mil).


Belite Bio Other Current Receivables Historical Data

The historical data trend for Belite Bio's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belite Bio Other Current Receivables Chart

Belite Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
0.04 0.02 0.02 0.87 0.59

Belite Bio Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 - - - 0.59

Belite Bio Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Belite Bio Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Belite Bio's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Belite Bio Business Description

Traded in Other Exchanges
Address
12750 High Bluff Drive, Suite 475, San Diego, CA, USA, 92130
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.